Phocas Financial Corp. lessened its position in Plexus Corp. (NASDAQ:PLXS – Free Report) by 0.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 55,372 shares of the technology company’s stock after selling 400 shares during the quarter. Phocas Financial Corp. owned 0.20% of Plexus worth $5,440,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also added to or reduced their stakes in the company. CWM LLC grew its stake in shares of Plexus by 42.4% during the first quarter. CWM LLC now owns 413 shares of the technology company’s stock valued at $40,000 after buying an additional 123 shares during the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of Plexus by 1.3% in the fourth quarter. The Manufacturers Life Insurance Company now owns 10,780 shares of the technology company’s stock worth $1,110,000 after purchasing an additional 135 shares during the last quarter. Heron Financial Group LLC grew its stake in shares of Plexus by 5.8% in the first quarter. Heron Financial Group LLC now owns 2,543 shares of the technology company’s stock worth $248,000 after purchasing an additional 140 shares during the last quarter. Quadrant Capital Group LLC grew its stake in shares of Plexus by 10.1% in the fourth quarter. Quadrant Capital Group LLC now owns 1,539 shares of the technology company’s stock worth $158,000 after purchasing an additional 141 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its stake in shares of Plexus by 0.9% in the second quarter. Price T Rowe Associates Inc. MD now owns 16,381 shares of the technology company’s stock worth $1,286,000 after purchasing an additional 153 shares during the last quarter. Institutional investors own 92.91% of the company’s stock.
Insiders Place Their Bets
In other Plexus news, CEO Todd P. Kelsey sold 720 shares of Plexus stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $103.00, for a total value of $74,160.00. Following the completion of the sale, the chief executive officer now owns 115,165 shares of the company’s stock, valued at approximately $11,861,995. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, CEO Todd P. Kelsey sold 720 shares of the business’s stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $103.00, for a total transaction of $74,160.00. Following the completion of the sale, the chief executive officer now owns 115,165 shares of the company’s stock, valued at approximately $11,861,995. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Todd P. Kelsey sold 2,000 shares of the business’s stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $99.00, for a total transaction of $198,000.00. Following the sale, the chief executive officer now directly owns 117,885 shares of the company’s stock, valued at approximately $11,670,615. The disclosure for this sale can be found here. In the last quarter, insiders sold 8,720 shares of company stock valued at $854,160. Company insiders own 2.05% of the company’s stock.
Plexus Stock Up 0.7 %
Plexus (NASDAQ:PLXS – Get Free Report) last posted its earnings results on Wednesday, July 26th. The technology company reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.15 by $0.17. Plexus had a net margin of 3.46% and a return on equity of 14.79%. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. As a group, equities analysts forecast that Plexus Corp. will post 5.53 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
PLXS has been the topic of several recent analyst reports. StockNews.com assumed coverage on Plexus in a research note on Thursday, August 17th. They issued a “hold” rating on the stock. Needham & Company LLC raised their price objective on shares of Plexus from $105.00 to $107.00 and gave the stock a “buy” rating in a report on Friday, July 28th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, Plexus currently has an average rating of “Hold” and an average target price of $106.80.
View Our Latest Report on PLXS
Plexus Profile
Plexus Corp., together with its subsidiaries, provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Stories
- Five stocks we like better than Plexus
- How to Invest in Cannabis, Step by Step
- Hold-It-Forever AutoZone Pulls into Buy Zone
- How to Invest in Lithium and Lithium Stocks
- Virtual Riches: 3 Stocks Leading the VR Revolution
- What Are Dividend Champions? How to Invest in the Champions
- 5 eCommerce Companies that need to be on Your Watch List
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.